Vitamin Financial Statements From 2010 to 2021

VTMB -  USA Stock  

USD 0.0001  0.00  0.00%

Vitamin Blue financial statements provide useful quarterly and yearly information to potential Vitamin Blue investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Vitamin Blue financial statements helps investors assess Vitamin Blue's valuation, profitability, and current liquidity needs.
Vitamin Blue does not presently have any fundamental trend indicators for analysis.

Vitamin Financial Statements 

Check Vitamin Blue financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vitamin main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Vitamin financial statements analysis is a perfect complement when working with Vitamin Blue Valuation or Volatility modules. It can also supplement various Vitamin Blue Technical models. Also, please take a look at the analysis of Vitamin Blue Correlation against competitors.

Vitamin Current Ratio Analysis

Vitamin Blue's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Ratio 
Current Asset 
Current Liabilities 
More About Current Ratio | All Equity Analysis

Current Vitamin Blue Current Ratio

  0.04 X  
Most of Vitamin Blue's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vitamin Blue is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Compare to competition

In accordance with the recently published financial statements, Vitamin Blue has a Current Ratio of 0.04 times. This is 98.24% lower than that of the Consumer Cyclical sector and 98.1% lower than that of the Leisure industry. The current ratio for all United States stocks is 98.15% higher than that of the company.

Vitamin Blue Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Vitamin Blue's current stock value. Our valuation model uses many indicators to compare Vitamin Blue value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vitamin Blue competition to find correlations between indicators driving Vitamin Blue's intrinsic value. More Info.
Vitamin Blue is rated third in total asset category among related companies. It is rated third in number of employees category among related companies . The ratio of Total Asset to Number of Employees for Vitamin Blue is about  35,000 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Vitamin Blue by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Vitamin Blue's OTC Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vitamin Blue's earnings, one of the primary drivers of an investment's value.

About Vitamin Blue Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Vitamin Blue income statement, its balance sheet, and the statement of cash flows. Vitamin Blue investors use historical funamental indicators, such as Vitamin Blue's revenue or net income, to determine how well the company is positioned to perform in the future. Although Vitamin Blue investors may use each financial statement separately, they are all related. The changes in Vitamin Blue's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Vitamin Blue's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Vitamin Blue Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Vitamin Blue. Please read more on our technical analysis and fundamental analysis pages.
Vitamin Blue, Inc. designs, develops, produces, and distributes water boardsports apparel and related products primarily in the United States. Vitamin Blue, Inc. was founded in 1999 and is based in Costa Mesa, California. Vitamin Blue operates under Leisure classification in the United States and is traded on OTC Exchange. It employs 1 people.

Vitamin Blue Investors Sentiment

The influence of Vitamin Blue's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Vitamin. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vitamin Blue in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vitamin Blue's short interest history, or implied volatility extrapolated from Vitamin Blue options trading.

Current Sentiment - VTMB

Vitamin Blue Investor Sentiment

Most of Macroaxis users are at this time bullish on Vitamin Blue. What is your outlook on investing in Vitamin Blue? Are you bullish or bearish?
98% Bullish
2% Bearish

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity..
Also, please take a look at the analysis of Vitamin Blue Correlation against competitors. Note that the Vitamin Blue information on this page should be used as a complementary analysis to other Vitamin Blue's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Vitamin OTC Stock analysis

When running Vitamin Blue price analysis, check to measure Vitamin Blue's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vitamin Blue is operating at the current time. Most of Vitamin Blue's value examination focuses on studying past and present price action to predict the probability of Vitamin Blue's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Vitamin Blue's price. Additionally, you may evaluate how the addition of Vitamin Blue to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Fundamental Analysis
View fundamental data based on most recent published financial statements
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Is Vitamin Blue's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vitamin Blue. If investors know Vitamin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vitamin Blue listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Vitamin Blue is measured differently than its book value, which is the value of Vitamin that is recorded on the company's balance sheet. Investors also form their own opinion of Vitamin Blue's value that differs from its market value or its book value, called intrinsic value, which is Vitamin Blue's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vitamin Blue's market value can be influenced by many factors that don't directly affect Vitamin Blue's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vitamin Blue's value and its price as these two are different measures arrived at by different means. Investors typically determine Vitamin Blue value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vitamin Blue's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.